Hill County passed what may be Texas' first county-wide data center ban, blocking eight proposed facilities. The move reflects growing resistance to data center expansion across the state.
Hill County commissioners enacted a one-year moratorium on new data center construction, halting plans for eight facilities in the region. The ban may represent the first county-level restriction of its kind in Texas.
The decision reflects broader opposition to data center proliferation, a concern emerging in regions led by both Democrats and Republicans. As data centers expand rapidly across the country, local officials increasingly grapple with balancing economic development against community impacts—including power consumption, land use, and infrastructure strain.
Texas trails only Virginia in data center concentration, making it a prime target for industry expansion. The state's affordable electricity and business-friendly environment have attracted significant investment from major cloud providers and tech companies.
Hill County's one-year moratorium provides time for officials to develop long-term policies governing data center development. The ban's outcome could influence how other Texas counties approach similar pressures.
The UK government has dismissed Green party leader Zack Polanski's proposal for a moratorium on large-scale AI datacentre construction, citing economic concerns over the energy and water-intensive projects.
ChangXin Memory Technologies (CXMT), China's leading memory chip producer, filed a lawsuit against the Pentagon on Friday challenging its designation as a Chinese military company. CXMT denies military affiliation and claims its chips are for civilian use only.
A US appeals court has ruled against Kalshi's attempt to block Nevada from regulating its platform, determining that the prediction market platform cannot escape state gambling laws by rebranding bets as 'swaps.'
Vijay Pande has left Andreessen Horowitz's $4 billion biotech practice to launch VZVC, a smaller AI-native venture fund focused on transforming drug discovery through engineering principles rather than traditional discovery methods.